Recently, extracted teeth have been identified as a viable source of stem cells for tissue regenerative approaches. Current expansion of these cells requires incorporation of animal sera; yet, a fundamental issue underlying cell cultivation methods for cell therapy regards concerns in using animal sera. In this study, we investigated the development of a chemically defined, serum-free media (K-M) for the expansion of human periodontal ligament stem cells (PDLSCs) and human stem cells from exfoliated deciduous teeth (SHEDs). Proliferation assays were performed comparing cells in serum-containing media (FBS-M) with cells cultured in four different serum-free medium and these demonstrated that in these medium, the cell proliferation of both cell types was significantly less than the proliferation of cells in FBS-M. Additional proliferation assays were performed using pre-coated fibronectin (FN) tissue culture plates and of the four serum-free medium, only K-M enabled PDLSCs and SHEDs to proliferate at higher rates than cells cultured in FBS-M. Next, alkaline phosphatase activity showed that PDLSCs and SHEDs exhibited similar osteogenic potential whether cultured in K-M or FBS-M, and, additionally, cells retained their multipotency in K-M as seen by expression of chondrogenic and adipogenic genes, and positive Von Kossa, Alcian blue, and Oil Red O staining. Finally, differential expression of 84 stem cell associated genes revealed that for most genes, PDLSCs and SHEDs did not differ in their expression regardless of whether cultured in K-M or FBS-M. Taken together, the data suggest that K-M can support the expansion of PDLSCs and SHEDs and maintenance of their multipotency.
Cell therapy has tremendous potential in regenerative medicine, yet, there are concerns in the utility of cell therapy due to questions regarding different cell harvest and cultivation methods (Mannello and Tonti, 2007; Haack-Sorensen et al., 2008) . Bone marrow derived stem cells have been identified for a number of years, and there are several of ongoing clinical trials exploring the safety and efficacy of their use for different of clinical applications (Battiwalla and Hematti, 2009; Sadan et al., 2009; Satija et al., 2009 ). There has been an increased interest in recent years in the potential of oral-derived stem cells for cell therapy, primarily because they can be derived from a readily available source, extracted teeth (Gronthos et al., 2000; Miura et al., 2003; Seo et al., 2004) . These cells exhibit multipotency and regenerative capacities characteristic of mesenchymal stem cells (Batouli et al., 2003; Shi et al., 2005) and have the capacity to repair and regenerate tooth structures in vivo (Krebsbach and Robey, 2002; Mao et al., 2006) . Because oral-derived stem cells have been more recently identified, clinical protocols are still being developed for their use. Regardless of the specific protocol used, most current cell therapy approaches rely upon ex vivo cell expansion in order to produce sufficient cell numbers for transplantation. Though a wide variety of protocols and culturing methods exist, one common aspect to most of them is the inclusion of animal sera for cell expansion, in that it contains a rich source of nutrients and growth factors (Mannello and Tonti, 2007) . Despite the widespread standard use of animal sera for in vitro cell culture (Freshney, 2000) , there are several problems which exist relative to its use for clinical application.
One of the central issues regarding limitations in using animal sera for clinical cell therapy protocols is that its components are highly variable and, in many cases, unknown. Though components of sera have been identified, it has also been demonstrated that consistency between different lots cannot be assured (Price and Gregory, 1982) . In the context of multipotent stem cells, serum components and concentrations have significant impact on cell survival and proliferative capacity, phenotype, and multipotent potential (Sotiropoulou et al., 2006; Agata et al., 2009) . Additionally, for clinical use, the inclusion of xenogeneic serum for cell expansion carries immunological risks associated with the immunogenicity of serum proteins and the potential of transmission of prion diseases and zoonoses (Shahdadfar et al., 2005) . These concerns have led to efforts aimed at incorporating FBS alternatives in cell expansion protocols, including the use of autologous and allogeneic sera, and the proprietary manufacturing of serum-free media formulations by different companies (Nakamura et al., 2008) . Even with these approaches, there are limitations in the availability of both autologous and allogeneic sera and companies do not freely disclose their proprietary ''serum-free'' media components. These factors not only prohibit clinical translation, but also limit widespread use and study of more basic fundamental questions regarding specific mechanisms involved in the modulation of these media on cell function. As such, there exists a need for the development of chemically defined media which can propagate the cultivation of stem cells without adversely affecting cell function and phenotype (Mannello and Tonti, 2007) .
In this study, we aimed to develop a serum-free media (K-M) for the expansion of dental-derived stem cells, including stem cells-derived from exfoliated deciduous (baby) teeth (SHEDs) and periodontal ligament stems cells (PDLSCs). Cell expansion in this media was compared to standard FBS containing media used to culture these cells, as well as three other serum-free media formulations (two of which are commercially available) used for culture of mesenchymal stem cells. Additionally, through differentiation assays and microarray analyses, multipotency and differential gene expression of 84 stem cell associated genes was examined between cells cultured in K-M versus those cultured in FBS-containing media.
Materials and Methods
Isolation of dental-derived stem cells (PDLSCs, SHEDs) PDLSCs and SHEDs were harvested as previously described Seo et al., 2004) . Briefly, PDLSCs were scraped from the root surface of a tooth into a p60 dish containing minimum essential alpha medium (aMEM, Gibco, Carlsbad, CA) and SHEDs were harvested by scraping out the dental pulp tissue from a deciduous tooth into a p60 dish containing aMEM. After collection, the cells were centrifuged at 1,600 rpm for 5 min at room temperature. The supernatant was aspirated and the cells were resuspended in a phosphate buffered saline (PBS; Gibco #14190) solution with 4 mg/ml Dispase II (Roche #04 942 078 001) and 2 mg/ml Collagenase Type II (Worthington #LS004196) and incubated at 378C for 60 min. The enzyme solution was inactivated with 5 ml of aMEM-15% FBS-100 mM ascorbic acid 2 phosphate (ASAP, Sigma A-8960, St. Louis, MO) and centrifuged at 1,600 rpm for 5 min at room temperature. Cells were resuspeneded in 5 ml aMEM-15% FBS-0.1 mM ASAP and transferred to T-25 flasks. Media was changed the next day and then every 2-3 days.
Cell culture
Cells were expanded in culture in aMEM, Iscove's modified Dulbecco's media (IMDM, Gibco-Invitrogen #12571), Gibco Stem Pro Mesenchymal Stem Cell Serum-Free Media (MSCSFM; Invitrogen #A1033401, Carlsbad, CA) or Lonza Therapeak Mesenchymal Stem Cell Growth, Media-Chemically Defined (Walkersville, MD) (MSCGM-CD; Lonza #00190632) and grown in a 378C humidified tissue culture incubator at 5% CO 2 . Media formulations are as follows: aMem (Gibco-Invitrogen #12571) with 15% FBS (Gibco-Invitrogen-16000), 100 mM ASAP and 5 mg/ ml Gentamicin (Invitrogen # 15750060) (FBS-M); aMem with 2% bovine serum albumin (BSA; Sigma A7888), 10 mg/ml human insulin (Sigma), 4 mg/ml low density lipoprotein, 200 mg/ml transferrin, 10 nM dexamethasone, 100 mM ASAP, 50 mM b-mercaptoethanol, 5 mg/ml gentamicin, 10 ng/ml platelet-derived growth factor (PDGF; Sigma), 10 ng/ml epidermal growth factor (EGF; R&D Systems), 10 ng/ml basic fibroblast growth factor (b-FGF, Sigma) (SDM); IMDM with 0.2% BSA, SITE 3 (Sigma #S5295), 384 mM ASAP, 10 ng/ml PDGF, 10 ng/ml hydrocortisone 5 ng/ml b-FGF, 1 ng/ml EGF, 10 À7 mg/ml parathyroid hormone (PTH) and 5 mg/ml gentamicin (K-M). Media on the cells were changed every 2 or 3 days. Cells were grown in T-150 flasks to about 80% confluency then media was aspirated from the flasks, cells were washed with PBS and trypsinized with TrypLE Express (Gibco #12605) before being split into 12 well plates for the assays. . The plates and flasks were tilted back and forth to ensure complete coverage of the FN solution. The FN coating was allowed to stand at room temperature for 90 min. The FN solution was then aspirated before the resuspended cells were transferred to the flasks and plates.
Proliferation assays
After trypsinization cells were resuspended in an equal amount of the appropriate media before an aliquot was removed for counting on a hemocytometer to determine the concentration. The cells were then centrifuged at $1,600 rpm for 5 min at room temperature. Cells were resuspended in the appropriate media at a concentration of 3,800 cells/ml. One milliliter of cells was dispensed into each well of a 12 well plate. K-M plates were precoated with FN solution (as outlined above). Four plates for each cell type and media condition were plated and counted on a hemocytometer at Days 1, 3, 5, and 7 to determine the cell numbers within each well. All experiments were performed in triplicate.
RNA isolation and purification for microarray
PDLSCs and SHEDs were grown in T-75 flasks to 80% confluency before the cells were harvested for RNA. The Trizol method (Invitrogen) was used for RNA isolation. This involved adding Trizol directly to the cells and transferring this cell suspension to polypropylene tubes. RNA was isolated from the cells by a Trizol-choloroform extraction, isopropanol precipitation, an ethanol rinse and resuspension of the RNA pellet in Diethylpyrocarbonate (DEPC) water. The RNA was further purified by column chromatography, following manufacturer's instructions (Qiagen RNeasy Kit #74104), and resuspended in DEPC water. RNA concentration was determined by the 260/280 absorbance measurement using a Beckman DU540 spectrophotometer.
In vitro multilineage differentiation
Multipotency of PDLSCs and SHEDs was determined through lineage specific osteogenic, chondrogenic, and adipogenic induction, according to previously described methods (Pittenger et al., 1999) . Briefly, cells were plated at a density of 30,000 cells/well in 12 well plates. At 80% confluency cells were induced with osteogenic [growth media plus 5 mM b-glycerophosphate, 100 nM dexamethasone, 50 mM ascorbic acid 2-phosphate] or chondrogenic [growth media plus 50 mM ascorbic acid 2-phosphate, 100 nM dexamethasone, 5 mg/ml human insulin (Sigma I-9278), 1 ng/ml TGFb, 400 mM proline, 1Â non-essential amino acids] or adipogenic [growth media plus 0.5 mM IBMX, 1 mM dexamethasone, 10 mg/ml human insulin, 200 mM indomethacin] induction media. Cells were grown at 378C in a humidified 5% CO 2 incubator. The media was changed every 2-3 days. At 3 weeks the cells were fixed and stained as outlined below.
Multipotent staining of PDLSCs and SHEDs
To identify the mineralized nodules, induced PDLSCs and SHEDs were fixed in 4% paraformaldehyde for 30 min, immersed in fresh 5% silver nitrate and incubated in the dark for 30 min. After washing in water the PDLSCs and SHEDs were exposed to ultraviolet light for 30 min followed by a 4 min incubation in 1% sodium thiosulfate to neutralize the silver nitrate. Cells were washed twice with water before 1 ml of PBS was added to each well and viewed. Plates were stored at 48C.
To detect chondrogenic differentiation induced PDLSCs and SHEDs were fixed in cold 100% methanol for 30 min and then exposed to 1% alcian blue in 0.1 N HCl for 30 min. Cells were washed twice with 0.1 N HCl before 1 ml of PBS was added to each well and viewed. Plates were stored at 48C.
To detect adipogenic differentiation by identifying lipid vesicles, induced PDLSCs and SHEDs were fixed in 4% paraformaldehyde for 30 min, and then immersed in 0.3% oil red O solution for 30 min. Cells were washed twice with water before 1 ml of PBS was added to each well and viewed. Plates were stored at 48C.
Alkaline phosphatase activity and detection
Early osteogenic differentiation was detected and quantified by the alkaline phosphatase (ALP) enzyme assay. Cells were plated at a density of 30,000 cells/well in 12 well plates. At 80% confluence, cells were induced with osteogenic media as described above. The media was changed every 2-3 days and after 1 week, ALP activity was measured.
To detect phosphatase activity, PDLSCs and SHEDs were fixed in 70% ethanol for 30 min. They were then incubated with freshly made substrate containing naphthol AS-TR phosphate (Sigma) and Fast blue (Sigma) for 30 min. Cells were washed twice with PBS then viewed or stored at 48C.
To quantify the ALP activity and normalize the results, cells were lysed in Passive Lysis Buffer (Promega, Madison, WI) according to manufacturer's instructions. Cell lysates were then sonicated, and centrifuged (10,000 rpm for 10 min at 48C). The supernatant was recovered for the quantitative colormetric ALP assay (Manolagas et al., 1981) and the cell pellet was used for DNA isolation and the determination of the DNA concentration using the Quant-iT TM dsDNA BR Assay (Invitrogen) per the manufacturer's instructions.
Reverse transcriptase polymerase chain reaction (RT-PCR)
To confirm chondrogenic and adipogenic differentiation, total PDLSC and SHED cellular RNA was extracted, reverse transcribed, and amplified using osteoblast specific gene primers. Media from the wells of induced and uninduced PDLSCs and SHEDs were aspirated. Cells were immediately resuspended in 1 ml of Trizol (Invitrogen) and RNA was isolated according to the manufacturer's instructions. Synthesis of cDNA was performed using Invitrogen's SuperScriptII kit and oligo dT. PCR reaction components and concentrations were as described in the Invitrogen Platinum Taq polymerase instructions using the primer sets below. An MJ themorcycler was used for the following two PCR reaction conditions:
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C 2 minutes ! ½94 Statistical analysis was performed with the use of Instat software (GraphPad Software, San Diego, CA). All data were plotted as mean AE standard error of the mean (SEM), unless otherwise noted. Statistically significant differences were determined by two-tailed Student t tests, and statistical significance was defined as P < 0.05.
Results

Cell growth and proliferation
PDLSCs and SHEDs were cultured for 7 days in four different media formulations and their proliferative potential was compared to cells grown in FBS-M. In all serum-free conditions, after 3 days, the cell proliferation of both cell types was <70% of the proliferation rate of cells grown in FBS-M and by day 5, this decreased to <50%. Neither of the cell types proliferated to the same degree as cells grown in FBS-M, though cells seemed to grow best in the Lonza media and K-M, particularly the SHEDs (Fig. 1a,b) . Additionally, relative to cell cultures in the FBS-M, in all cultures grown in serum-free media there were larger numbers of floating and non-adhering cells at Day 1 and throughout the timecourse of the study. This suggested that the cells did not have sufficient initial adherence, limiting their capacity to sustain cell growth over time.
The next set of studies followed from the first set and aimed to evaluate the cell adhesive and proliferative effect of providing an extracellular matrix (ECM) coating on the cell culture growth surface. PDLSCs and SHEDs were expanded in K-M and Lonza medium and FN was coated on these tissue culture plates prior to plating of cells. Over time, PDLSCs and SHEDs cultured in K-M exhibited morphology no different than those seen in Fig. 2a-d) . The proliferation assays revealed that when grown in K-M, PDLSCs in K-M exhibited significantly higher proliferation rates by day 7 (Fig. 2e ) when compared to PDLSCs cultured in FBS-M. On the other hand, by day 5 of the 7-day timecourse, SHEDs proliferated at significantly ( P < 0.05) higher rates than cells in FBS-M (Fig. 2f ).
Though the Lonza media supported the proliferation of SHEDs equivalent to that seen in K-M, PDLSCs in this media did not proliferate to the same degree as in the control FBS-M or K-M. Similar proliferation assays were conducted with dental pulp stem cells (DPSCs) and bone marrow derived stem cells (MSCs) and the K-M did not support proliferation of either cell type to the same degree as the FBS-M (data not shown).
Differential gene expression of PDLSCs and SHEDs in K-M versus FBS-M
Both PDLSCs and SHEDs cultured in K-M exhibited a greater proliferative capacity than when cultured in FBS-M, and thus, we next wanted to determine if K-M had effects on gene expression of these two cell types. Eighty-four stem cell associated genes were analyzed for differential expression when cells were cultured in K-M relative to when cultured in FBS-M. Following 1 week of culture in the respective media, genes associated with ''stemness'' and lineage specific genes were analyzed with RT-PCR microarray and genes exhibiting a greater than twofold difference in expression between the conditions were reported. Table 1 shows upregulated ''stemness'' associated genes when PDLSCs were cultured in K-M, relative to FBS-M. Overall, the K-M media appeared to support a significant (>2-fold) upregulation in expression of genes associated with mesenchymal stem cells and ''stemness,'' particularly when compared to downregulated gene expression of ''stemness'' 6.4 Integrin, alpha X (CD11c) 4.1
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and mesenchymal stem cell associated genes (Table 2) . Differential expression (up-and down-regulation) of lineage specific genes is also seen between the two culture conditions, but only for a few lineage specific genes (Tables 1 and 2 ). In analysis of differential gene expression of SHEDS grown in the two different media, there appeared to be the same degree of up-and down-regulation of different ''stemness'' associated genes and lineage specific genes (Tables 3 and 4) . Taken together, these data suggest that while expansion of SHEDs in K-M resulted in differential expression of different genes associated with ''stemness'' and lineage specific differentiation, there appeared to be no net difference in the number of up-and down-regulated genes. Yet, for PDLSCs cultured between the two conditions, the K-M appeared to ''hold'' cells in a greater state of ''stemness,'' as evidenced by the upregulation of ''stemness'' associated genes when cultured in this media.
Osteogenic potential of PDLSCs and SHEDs in K-M
Because PDLSCs and SHEDs have demonstrated the capacity for osteogenic differentiation when cultured in the presence of osteogenic inductive factors, we examined the ability of K-M to support the growth of PDLSCs and SHEDS while maintaining their capacity for osteogenic differentiation. To evaluate this, cells were expanded for 7 days in either K-M or FBS-M and then cultured in osteoinductive media (containing FBS) for 7 days. Alkaline phophatase activity was analyzed quantitatively following 1 week of culture in osteoinductive media and in both SHEDs and PDLSCs, there were no differences in Alk-P activity between cells expanded in K-M versus those expanded in FBS-M (Fig. 3a,b) . This demonstrated that both cell types maintained their capacity for osteogenic differentiation following cell expansion in K-M.
Maintenance of PDLSC and SHED multilineage potential in K-M
PDLSCs and SHEDS were assessed for their capacity to differentiate towards different cellular lineages following cell expansion in K-M and FBS-M. Lineage specific induction under traditional adipogenic, chondrogenic, and osteogenic conditions was performed and these conditions incorporated serum in the induction media. Following 1 week of induction, RT-PCR was performed to examine gene expression of adipogenic (PPARg2, LPL) ( Fig. 4a) and chondrogenic (SOX9, coll. II) (Fig. 4b) (Fig. 5a) . Similarly, in cells grown under chondrogenic conditions following culture expansion in either FBS-M or K-M, the presence of chondrogenic proteoglycans was indicated by positive Alcian blue staining (Fig. 5a) , confirming chondrogenic differentiation. In adipogenic conditions, Oil Red O staining was used to detect intracellular lipid-rich vacuoles and morphological changes in cell shape. The results confirmed that under these conditions, PDLSCs expanded in either FBS-M or K-M exhibited no difference in their capacity to differentiate toward an adipogenic lineage (Fig. 5a) . As was the case with the PDLSCs, SHEDs expanded in FBS-M or K-M exhibited comparable levels of differentiation towards osteogenic, chondrogenic, and adipogenic lineages as 2.2 Growth differentiation-6 (GDF-6) 2.1 evidenced through similar patterns of Von Kossa, Alcian Blue, and Oil Red O staining (Fig. 5b) .
Discussion
Oral-derived stem cells have clinical potential for cell therapy applications in craniofacial regeneration; yet, one of the possible limitations with the clinical utility of these cells is that all current cell culture protocols for their expansion incorporate animal sera. In this report, we describe the development of a chemically defined, serum-free media (K-M) for the cell expansion of dental-derived stem cells. PDLSCs and SHEDs cultured in K-M proliferated at rates faster than when these cells were cultured in media containing serum (FBS-M). Microarray analyses showed that overall, PDLSCs and SHEDs in K-M expressed more ''stemness'' markers, when compared to those cells in FBS-M. Finally, PDLSCs and SHEDs were able to maintain their capacity for osteogenic differentiation as well as their multilineage potential following culture in K-M. It has been well-established that the components of serum contain rich nutrients and growth factors which support cell growth in culture (Price and Gregory, 1982; Satija et al., 2007 ). Yet, in the context of clinical applications, efforts to develop chemically defined, serum-free media to support growth of different mesenchymal cell types are not new (Koller et al., 1998; Sotiropoulou et al., 2006; Mannello and Tonti, 2007) . From a biology standpoint, the development of serum deprived growth media enables the study of growth factors, hormones and other compounds on cell cultures without the confounding effects of the possible presence of these components in serum (Lennon et al., 1995) . Serum-free media has been examined for the cell expansion of bone marrow-derived stromal cells, and more recently, commercially developed serum-free media and serum substitutes have been developed for these cells. Despite the variety of different formulations examined, there appear to be a few common elements of animal sera to which all serumfree media formulations aim to replace or substitute, including: vitamins, hormones, transport proteins, essential elements, lipids, and growth factors. Because marrow derived mesenchymal stem cells share similar properties with certain populations of oral-derived stem cells, we took a similar approach in our efforts to develop a serum-free media for oral-derived stem cells. Replacement of an often overlooked component of serum, vitamins, served as the rationale in using IMDM media as the basal media. It contains high concentrations of vitamins and glucose, relative to other commonly used basal media (i.e., DMEM, aMEM) for cell culture. Another important source of key components was derived from the SITE 3 supplement, which provided transferrin and a source of lipids and trace elements. Transferrin, due to its iron-binding properties, is a critical component of chemically defined media due to its ability to transport iron (an essential trace element) across cell membranes (Barnes and Sato, 1980; Lennon et al., 1995) . Selenium, also an essential trace element, is contained within the SITE 3 supplement as well, and is involved in cell growth (McKeehan et al., 1976) . The other components of SITE 3 are insulin, ethanolamine, linoleic acid, and oleic acid. Insulin is a hormone that promotes the uptake of glucose and amino acids and serves as a mitogen for in vitro culture of cells due to its role in fatty acid and glycogen syntheses. The fatty acids (ethanolamine, linoleic acid, and oleic acid) are important nutrients for many cells in that they are involved in cell growth and also serve as key components of the cell membrane (Murakami et al., 1982; Kovar, 1987) . Finally, serum bovine albumin (BSA) is contained within SITE 3 and due to the critical role it plays as a fatty acid carrier (Guilbert and Iscove, 1976; Nilausen, 1978) , additional BSA was directly added to the K-M culture medium at a concentration of 0.2%.
Other key components of the K-M media were ascorbic acid, exogenous hormones (PTH and hydrocortisone), and growth factors (PDGF, EGF, FGF) . Though ascorbic acid is often incorporated into ''osteoinduction media'' for mesenchymal cells (Pittenger et al., 1999) , historically, it has been implicated in the biosynthesis of extracellular matrix components such as collagen and increases the cell proliferation of mesenchymal cells in culture (Hata and Senoo, 1989; Harada et al., 1991) . PTH has been shown to be required for serum-free growth of cell cultures (Bottenstein et al., 1979) and in testing of 37 lots of fetal bovine serum, Price and Gregory found that serum lots contained on average, 1,718 pg/ml, with ranges between 85 and 6,180 pg/ml (Price and Gregory, 1982) . Thus, we incorporated this into the K-M but in comparison to when it was not added to the media, no effects were observed on proliferation and gene expression of mesenchymal markers (data not shown). On the other hand, though we did not perform separate studies with or without inclusion of growth factors, inclusion of PDGF, EGF, and b-FGF in serum-free medium for bone marrow derived mesenchymal stem cells has been shown to be critical for cell proliferation and in vitro colony-forming potential (Gronthos and Simmons, 1995; Lennon et al., 1995; Kuznetsov et al., 1997) . Through the utilization of blocking antibodies in serum-free media containing marrow stromal cell conditioned media, Kuznetsov et al. determined that the proliferation of marrow stromal fibroblasts requires participation of at least four growth factors: PDGF, bFGF, TGF-beta, and EGF. These results are in accord with findings from Lennon et al., which demonstrated that addition of PDGF and FGF to serum-free cultures of mesenchymal stem cells are critical in maintaining proliferation rates comparable to rates seen when cells are cultured in FBS. In the context of colony forming potential (CFU-F), through a series of exhaustive experiments studying the effects of individual growth factors and growth factor combinations on colony formation of bone marrow derived stromal cells, Gronthos et al. determined that exogeneous growth factor inclusion into serum-free media is necessary for clonal growth and development (Gronthos and Simmons, 1995) . Though we did not examine CFU-F potential in these studies, we did examine proliferation rates of SHEDs, PDLSCs, and DPSCs with the media Gronthos et al. used in their studies and did not see proliferation of oral-derived stem cells beyond Day 5, with most of the cells beginning to die off and detach from the culture plates at this point. Though proliferation was observed in the K-M, we saw an increase in initial cell non-adherence and cell detachment over time, relative to cells cultured in FBS-M. This observation served as the rationale to incorporate the FN coating step as part of the cell expansion process, attempting to enhance cell adherence through utilization of an ECM coating on the tissue culture plates. The role of cell adhesion molecules contained in serum, namely fibronectin, has long been established. These molecules play important roles in promotion of cell attachment, proliferation, and differentiation and as such, efforts are often made in order to recapitulate the effects of these factors through the use of fibronectin, laminin, and collagen (Steele et al., 1993; Mauney et al., 2006) . In our system, we showed that the additional step of providing a FN coating upon which the cells could attach was pivotal in attaining cell (SHEDs, PDLSCs) proliferation rates in K-M comparable and greater than those seen in FBS-M.
Though it was clearly demonstrated that cells could be expanded in K-M on FN, it was more critical to determine if these cells could retain their multipotency following culture in K-M. When the switch was made to conventional ''lineage-specific induction'' conditions with the incorporation of FBS (Pittenger et al., 1999) , PDLSCs and SHEDs exhibited the ability to differentiate down osteogenic, adipogenic, and chondrogenic pathways. Though the PDLSCs and SHEDs were able to retain their capacity for differentiation following culture in K-M, the observation of an increase in proliferation rate suggested that the cells were less differentiated while growing in K-M, hence, exhibiting higher proliferative capacity. Further support that K-M appeared to maintain the cells in a less differentiated state, or greater state of ''stemness,'' was provided by the observation of greater expression of stemness markers during culture in K-M, particularly by the PDLSCs. Additionally, it should be noted that when attempts were made to osteogenically induce cells (as described in the Materials and Methods Section) while leaving in K-M, cells did not show the capacity for induction (data not shown), further suggesting that this media may be ''holding'' them in a greater state of ''stemness.'' If, in fact, this is the case, it could hold implications for therapeutic approaches to utilization of these cells. Of particular interest are the PDLSCs, which demonstrated significant upregulation (>2-fold) of 36 of the 84 stem cell associated genes analyzed when culture in K-M relative to FBS-M, the majority of these being genes associated with ''stemness'' or ''undifferentiated'' stem cell phenotypes. Further studies need to be performed in order to more clearly elucidate this hypothesis based on these initial observations.
As noted, due to concerns regarding the use of animal sera in cell therapy applications, there have been efforts to develop serum-free media formulations for the culture of bone marrow derived mesenchymal cells for the exploitation of their clinical utility. Serum-free media also allow more in depth study of specific growth factors effects on cells without the confounding factor of the various unknown components and effects of animal sera. Though oral-derived stem cells have similarities to bone marrow derived stem cells in their phenotypes and regenerative applications, a distinct therapeutic advantage of oral-derived stem cells is their availability, in that they are derived from non-functional tissues (i.e., extracted teeth). Though these studies provide early evidence of the development of a serum-free media capable of supporting the expansion and multipotency of PDLSCs and SHEDs, the true test of efficacy will be to determine if these cells cultured in K-M can retain their regenerative potential in vivo. Another key point to address will be to determine if these cells can be harvested, isolated, and expanded without ever being exposed to animal sera and further, if this impacts immunomodulatory properties these cells have been shown to possess (Wada et al., 2009) . Studies are currently being planned which aim to address these points and more rigorously elucidate some of the mechanistic effects of specific components of the K-M media on regulation of gene expression and modulation of cell phenotype.
